# FINASTERIDE AND TADALAFIL
> **ANDA218499** · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2025-03-19
## Drug
- **FDA Application Number:** ANDA218499
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** FINASTERIDE AND TADALAFIL
- **Generic name:** Finasteride
- **Active ingredients:** FINASTERIDE; TADALAFIL
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVITIUM PHARMA
- **First approval:** 2025-03-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218499)
---
*MORVS · CC0 1.0*